Influence of infection on exacerbations of multiple sclerosis - PubMed (original) (raw)
Influence of infection on exacerbations of multiple sclerosis
H S Panitch. Ann Neurol. 1994.
Abstract
Exacerbations of multiple sclerosis (MS) are triggered by exogenous events, the best documented being viral upper respiratory infections (URIs), which can stimulate secretion of cytokines such as interferon-gamma (IFN-gamma) by immune cells. In conjunction with a recent clinical trial of systemic interferon-beta (IFN-beta) in relapsing-remitting MS, we studied the occurrence of viral infections and their correlation with MS attacks. Thirty patients kept daily logs, noting URI symptoms in themselves, family members, and co-workers. Patients were examined every 3 months, or whenever an attack of MS occurred, and were tested for antibodies to common upper respiratory pathogens. A strong correlation was found between MS attacks and URIs. There were 168 URIs in 2,792 patient-weeks, including 996 weeks at risk (the interval beginning 1 week before and ending 5 weeks after onset of URI symptoms) and 1,796 weeks not at risk. Nearly two-thirds of attacks occurred in periods at risk. Attack rates were 2.92 per year in weeks at risk compared to 1.16 per year in weeks not at risk, a significant difference (p < 0.001). High-dose interferon reduced the frequency of MS attacks, but had no effect on the number of URIs. Although a specific virus could not be incriminated, we concluded that URIs of presumed viral origin are an important trigger of MS attacks, and that treatment with IFN-beta reduces the attack rate, but not by preventing URIs. Rather, it may modulate responses to viral infection that would otherwise lead to immune activation and clinical symptoms.
Similar articles
- The association of upper respiratory infections with neuro-radiological course and attack rate of multiple sclerosis: Results from a large prospective cohort.
Ghasemi M, Farazandeh D, Amini B, Sedaghat M, Najafi A, Khayatzadeh Kakhki S, Torabi P, Jafarimehrabady N, Bitaraf A, Shariati H, Gholampour G, Kazemi S, Naser Moghadasi A, Vajihinejad M. Ghasemi M, et al. Mult Scler J Exp Transl Clin. 2023 Sep 25;9(3):20552173231196992. doi: 10.1177/20552173231196992. eCollection 2023 Jul-Sep. Mult Scler J Exp Transl Clin. 2023. PMID: 37767104 Free PMC article. - Multiple sclerosis attacks are associated with picornavirus infections.
Kriesel JD, White A, Hayden FG, Spruance SL, Petajan J. Kriesel JD, et al. Mult Scler. 2004 Apr;10(2):145-8. doi: 10.1191/1352458504ms1005oa. Mult Scler. 2004. PMID: 15124758 - Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis.
Edwards S, Zvartau M, Clarke H, Irving W, Blumhardt LD. Edwards S, et al. J Neurol Neurosurg Psychiatry. 1998 Jun;64(6):736-41. doi: 10.1136/jnnp.64.6.736. J Neurol Neurosurg Psychiatry. 1998. PMID: 9647301 Free PMC article. Clinical Trial. - Rationale for early treatment with interferon beta-1a in relapsing-remitting multiple sclerosis.
Munschauer FE 3rd, Stuart WH. Munschauer FE 3rd, et al. Clin Ther. 1997 Sep-Oct;19(5):868-82. doi: 10.1016/s0149-2918(97)80041-0. Clin Ther. 1997. PMID: 9385476 Review. - A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type.
Nikfar S, Rahimi R, Abdollahi M. Nikfar S, et al. Clin Ther. 2010 Oct;32(11):1871-88. doi: 10.1016/j.clinthera.2010.10.006. Clin Ther. 2010. PMID: 21095482 Review.
Cited by
- Systemic inflammation associates with and precedes cord atrophy in progressive multiple sclerosis.
Stuart CM, Varatharaj A, Zou Y, Darekar A, Domjan J, Gandini Wheeler-Kingshott CAM, Perry VH, Galea I. Stuart CM, et al. Brain Commun. 2024 Apr 20;6(3):fcae143. doi: 10.1093/braincomms/fcae143. eCollection 2024. Brain Commun. 2024. PMID: 38712323 Free PMC article. - Association of helicobacter pylori with multiple sclerosis: Protective or risk factor?
Mirmosayyeb O, Barzegar M, Nehzat N, Najdaghi S, Ansari B, Shaygannejad V. Mirmosayyeb O, et al. Curr J Neurol. 2020 Apr 3;19(2):59-66. doi: 10.18502/cjn.v19i2.4942. Curr J Neurol. 2020. PMID: 38011437 Free PMC article. - The association of upper respiratory infections with neuro-radiological course and attack rate of multiple sclerosis: Results from a large prospective cohort.
Ghasemi M, Farazandeh D, Amini B, Sedaghat M, Najafi A, Khayatzadeh Kakhki S, Torabi P, Jafarimehrabady N, Bitaraf A, Shariati H, Gholampour G, Kazemi S, Naser Moghadasi A, Vajihinejad M. Ghasemi M, et al. Mult Scler J Exp Transl Clin. 2023 Sep 25;9(3):20552173231196992. doi: 10.1177/20552173231196992. eCollection 2023 Jul-Sep. Mult Scler J Exp Transl Clin. 2023. PMID: 37767104 Free PMC article. - Alzheimer's disease and multiple sclerosis: a possible connection through the viral demyelinating neurodegenerative trigger (vDENT).
Boukhvalova MS, Kastrukoff L, Blanco JCG. Boukhvalova MS, et al. Front Aging Neurosci. 2023 Jun 15;15:1204852. doi: 10.3389/fnagi.2023.1204852. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37396655 Free PMC article. - Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study.
Miele G, Cepparulo S, Abbadessa G, Lavorgna L, Sparaco M, Simeon V, Guizzaro L, Bonavita S. Miele G, et al. J Clin Med. 2023 Jan 28;12(3):1023. doi: 10.3390/jcm12031023. J Clin Med. 2023. PMID: 36769670 Free PMC article.
References
- Sibley WA, Bamford CR, Clark K. Triggering factors in multiple sclerosis In: Poser CM, Paty DW, Scheinberg L, et al. eds. The diagnosis of multiple sclerosis. New York, Thieme‐Stratton Inc, 1984: 14–24
- Panitch HS, Hirsch RL, Haley AS, Johnson KP. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987; 1: 893–895 - PubMed
- Andersen O, Lygner P‐E, Berstrom T, et al. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 1991; 240: 417–422 - PubMed
- Beck J, Rondot P, Catinot L, et al. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 1988; 78: 318–323 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical